Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline 2020-03-01
  2. Neurophysiological predictors of long term response to AChE inhibitors in AD patients 2005-08-01

Studies

2 studies carry this tag.

Date range

2005 to 2020

Top journals

  • Journal of neurology, neurosurgery, and psychiatry 1
  • Science translational medicine 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neurophysiological signatures in Alzheimer's disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Science translational medicine 2020-03-01 Brain scans and imaging

    Neural synchrony is intricately balanced in the normal resting brain but becomes altered in Alzheimer's disease (AD).

  2. Neurophysiological predictors of long term response to AChE inhibitors in AD patients

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurology, neurosurgery, and psychiatry 2005-08-01 Treatments

    Evaluation of SAI may be useful for identifying AD patients likely to respond to treatment with AChE inhibitors.

All topic tags with their study counts